The unified social credit code/registration number of Harbin Pharmaceutical Group Jiamusi Pharmaceutical Co., Ltd. is 91230800560601kloc-0/977, and the enterprise is in the state of opening.
The business scope of Harbin Pharmaceutical Group Jiamusi Pharmaceutical Co., Ltd. is: chemical pharmaceutical preparations, proprietary Chinese medicines, antibiotics, biochemical drugs, biological products, Chinese herbal pieces, protein assimilation preparations, peptide hormones, psychotropic drugs of category II, chemical raw materials and their preparations, pharmaceutical precursor chemicals, psychotropic drugs of category II, toxic pharmaceutical preparations for medical use (arsenic trioxide injection), toxic pharmaceutical preparations for medical use (botulinum toxin A) and medical devices. Sanitary products, fitness equipment, disinfection products (excluding pre-licensing items), cosmetics, health products, family planning products, health food, prepackaged foods wholesale and retail, conference and exhibition services, medicine and medical consulting services. In Heilongjiang province, the total registered capital of companies with similar business scope is 579.89 million yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, with *** 1.
See more information and materials of Jiamusi Pharmaceutical Co., Ltd. of Harbin Pharmaceutical Group through Aiqi.